Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Bodil Petersen; Klaus Bendtzen; Nils Koch-Henriksen; Mads Ravnborg; Christian Ross; Per Soelberg Sorensen; Danish Multiple Sclerosis Group

Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Bodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, Mads Ravnborg, Christian Ross, Per Soelberg Sorensen, Danish Multiple Sclerosis Group

45 Citations (Scopus)

Abstract

The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.

Original language	English
Journal	Multiple Sclerosis
Volume	12
Issue number	3
Pages (from-to)	247-52
Number of pages	6
ISSN	1352-4585
Publication status	Published - 1 Jun 2006
Externally published	Yes

Cite this

@article{4af5c633fc0841768a66878b8abda75d,

title = "Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis",

abstract = "The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.",

author = "Bodil Petersen and Klaus Bendtzen and Nils Koch-Henriksen and Mads Ravnborg and Christian Ross and Sorensen, {Per Soelberg} and {Danish Multiple Sclerosis Group}",

year = "2006",

month = jun,

day = "1",

language = "English",

volume = "12",

pages = "247--52",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "Sage Science Press (UK)",

number = "3",

}

TY - JOUR

T1 - Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

AU - Petersen, Bodil

AU - Bendtzen, Klaus

AU - Koch-Henriksen, Nils

AU - Ravnborg, Mads

AU - Ross, Christian

AU - Sorensen, Per Soelberg

AU - Danish Multiple Sclerosis Group

PY - 2006/6/1

Y1 - 2006/6/1

N2 - The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.

AB - The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.

M3 - Journal article

C2 - 16764336

SN - 1352-4585

VL - 12

SP - 247

EP - 252

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 3

ER -

Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Abstract

Fingerprint

Cite this